EGFR and lung carcinoma: In addition to the PIK3CA/EGFR co-mutated PC-9-PIK3CA-M and HCC-827-PIK3CA-M cells, we also used H1975 and H1650 lung cancer cells to evaluate the synergetic effects of gefitinib and BYL719.